JP2024508780A5 - - Google Patents
Info
- Publication number
- JP2024508780A5 JP2024508780A5 JP2023550150A JP2023550150A JP2024508780A5 JP 2024508780 A5 JP2024508780 A5 JP 2024508780A5 JP 2023550150 A JP2023550150 A JP 2023550150A JP 2023550150 A JP2023550150 A JP 2023550150A JP 2024508780 A5 JP2024508780 A5 JP 2024508780A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound according
- item
- alkyl
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163151060P | 2021-02-18 | 2021-02-18 | |
| US63/151,060 | 2021-02-18 | ||
| PCT/IB2022/000074 WO2022175749A1 (en) | 2021-02-18 | 2022-02-18 | Compositions for conjugating oligonucleotides and carbohydrates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508780A JP2024508780A (ja) | 2024-02-28 |
| JP2024508780A5 true JP2024508780A5 (cg-RX-API-DMAC7.html) | 2025-02-26 |
Family
ID=81386899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550150A Pending JP2024508780A (ja) | 2021-02-18 | 2022-02-18 | オリゴヌクレオチドおよび炭水化物をコンジュゲートするための組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250034561A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4294449A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024508780A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117222434A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022175749A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116444589B (zh) * | 2023-06-15 | 2023-09-19 | 北京悦康科创医药科技股份有限公司 | 新型GalNAc化合物及其硫代寡核苷酸缀合物和偶联方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3121281B1 (en) | 2007-08-27 | 2021-03-31 | 1Globe Health Institute LLC | Compositions of asymmetric interfering rna and uses thereof |
| PL2992098T3 (pl) * | 2013-05-01 | 2019-09-30 | Ionis Pharmaceuticals, Inc. | Kompozycje i sposoby modulowania ekspresji hbv i ttr |
| JOP20160211B1 (ar) * | 2015-10-01 | 2021-08-17 | Arrowhead Pharmaceuticals Inc | تراكيب وأساليب لتثبيط تعبير جيني للـ lpa |
| WO2018185253A1 (en) * | 2017-04-05 | 2018-10-11 | Silence Therapeutics Gmbh | Ligand modified double-stranded nucleic acids |
| SG11202105900UA (en) * | 2018-12-10 | 2021-07-29 | Amgen Inc | CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF |
| TW202103698A (zh) * | 2019-04-18 | 2021-02-01 | 美商健生醫藥公司 | 用於治療b型肝炎病毒感染之組合療法 |
| EP4126967A1 (en) * | 2020-03-23 | 2023-02-08 | Amgen Inc. | Monoclonal antibodies to chemically-modified nucleic acids and uses thereof |
| KR20230104200A (ko) * | 2020-11-05 | 2023-07-07 | 암젠 인크 | LPA-표적화된 RNAi 작제물을 이용하여 죽상경화성 심혈관질환을 치료하는 방법 |
| WO2022152869A1 (en) * | 2021-01-15 | 2022-07-21 | Janssen Sciences Ireland Unlimited Company | Use of oligonucleotides for individuals with hepatic impairment |
-
2022
- 2022-02-18 US US18/277,846 patent/US20250034561A1/en active Pending
- 2022-02-18 EP EP22719012.1A patent/EP4294449A1/en active Pending
- 2022-02-18 JP JP2023550150A patent/JP2024508780A/ja active Pending
- 2022-02-18 WO PCT/IB2022/000074 patent/WO2022175749A1/en not_active Ceased
- 2022-02-18 CN CN202280015973.5A patent/CN117222434A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111343994B (zh) | 用于抑制血管生成素-样3 (ANGPTL3)的表达的RNAi剂和组合物以及使用方法 | |
| JP2022544587A5 (cg-RX-API-DMAC7.html) | ||
| JP6978099B2 (ja) | 4’−リン酸アナログ及びそれを含むオリゴヌクレオチド | |
| JP2022533841A5 (cg-RX-API-DMAC7.html) | ||
| CN109562188B (zh) | 与三价糖缀合物连接的核酸 | |
| JP2022533722A5 (cg-RX-API-DMAC7.html) | ||
| CN105164261B (zh) | 用于增强的细胞摄取的化合物和方法 | |
| JP7748500B2 (ja) | トリループを含む二本鎖核酸インヒビター分子 | |
| JP2020533334A (ja) | アポリポタンパク質C−III(APOC3)の発現を阻害するためのRNAi剤および組成物 | |
| JP2022534069A5 (cg-RX-API-DMAC7.html) | ||
| US20130059902A1 (en) | Methods and compositions useful in treatment of diseases or conditions related to repeat expansion | |
| US20180318330A1 (en) | Compounds and methods for modulating c90rf72 | |
| JP2021503929A5 (cg-RX-API-DMAC7.html) | ||
| JP2021503941A5 (cg-RX-API-DMAC7.html) | ||
| KR20240096846A (ko) | 알파-1 항트립신 (AAT) RNAi 작용제, AAT RNAi 작용제를 포함하는 조성물, 및 사용 방법 | |
| JP2022535708A5 (cg-RX-API-DMAC7.html) | ||
| JP2022533419A5 (cg-RX-API-DMAC7.html) | ||
| JP2022533421A5 (cg-RX-API-DMAC7.html) | ||
| CN105121452A (zh) | 三环核苷和由其制备的寡聚化合物 | |
| CN120118909B (zh) | 靶向调控LPA基因表达的siRNA双链体及其在预防和治疗心脑血管相关疾病中的用途 | |
| US6017895A (en) | Oligonucleotides possessing zwitterionic moieties | |
| JP2025526994A5 (cg-RX-API-DMAC7.html) | ||
| EP4353266A1 (en) | Ligand-bound nucleic acid complex | |
| CN120485189B (zh) | 靶向调控LPA基因表达的siRNA及其用途 | |
| HK40084990A (en) | 4'-oxymethylphosphonate nucleotide analogs and oligonucleotides comprising the same |